PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.\', \'Department of Environmental Health Sciences, University of Michigan, Ann Arbor, Michigan, USA.\', \'Department of Obstetrics & Gynecology, University of Michigan, Ann Arbor, Michigan, USA.\', \'Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.\', \'Michigan Institute for Clinical & Health Research, University of Michigan, Ann Arbor, Michigan, USA.\', \'Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.\', \'Department of Pharmacy, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.\', \'Department of Learning Health Sciences, University of Michigan, Ann Arbor, Michigan, USA.\', \'Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA.\', \'Department of Emergency Medicine, University of Michigan, Ann Arbor, Michigan, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciaa954
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 32651997
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all